Q1 2022 Holdings
Filed 2022-05-16 | 118 holdings | $24.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adma Biologics Inc(ADMA) | COM | 000899104 | $6.0M | 3,300,000 | 24.3% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $5.3M | 120,000 | 21.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $4.5M | 204,000 | 18.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $2.2M | 66,000 | 9.0% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $2.0M | 322,000 | 7.9% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.9M | 66,196 | 7.7% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $1.8M | 663,800 | 7.1% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $924.0K | 122,000 | 3.7% |
| Protagonist Therapeutics Inc(PTGX)Call | COM | 74366E102 | $11.8K | 5,000 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $11.6K | 2,496,524 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $10.0K | 1,450,006 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $9.1K | 386,000 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $8.9K | 545,000 | 0.0% |
| Pepperlime Health Acqustn Co | UNIT 99/99/9999 | G70021129 | $7.2K | 735,000 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $6.9K | 126,000 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $6.4K | 12,500 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $6.3K | 268,000 | 0.0% |
| Quidel Corp | COM | 74838J101 | $6.3K | 56,000 | 0.0% |
| Globus MED Inc(GMED) | CL A | 379577208 | $5.8K | 79,000 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $5.8K | 50,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $5.6K | 77,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $5.6K | 206,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $5.4K | 1,750,000 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $5.4K | 94,000 | 0.0% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $5.1K | 105,000 | 0.0% |
| Nocturne Acquisition Corp | ORDINARY SHARES | G6580S114 | $5.0K | 500,000 | 0.0% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $4.8K | 23,000 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $4.8K | 645,000 | 0.0% |
| Qiagen NV(QGEN) | SHS NEW | N72482123 | $4.6K | 93,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $4.5K | 243,000 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $4.4K | 920,000 | 0.0% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $4.2K | 6,246,291 | 0.0% |
| Verastem Inc | COM | 92337C104 | $4.2K | 2,951,000 | 0.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $4.1K | 16,000 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $4.1K | 50,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $4.0K | 236,000 | 0.0% |
| Eucrates Biomedical Acqu COR | SHS | G3141W106 | $3.9K | 400,000 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $3.8K | 11,000 | 0.0% |
| 1847 Goedeker Inc | *W EXP 06/02/202 | 28252C117 | $3.8K | 6,103,824 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $3.7K | 440,000 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $3.4K | 695,000 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $3.4K | 300,000 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $3.1K | 155,000 | 0.0% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $2.9K | 114,710 | 0.0% |
| Repro MED SYS Inc(KRMD) | COM | 759910102 | $2.8K | 995,500 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $2.7K | 224,541 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $2.7K | 21,000 | 0.0% |
| Turmeric Acquisition Corp | CL A | G9127T108 | $2.5K | 254,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $2.4K | 60,000 | 0.0% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $2.4K | 52,007 | 0.0% |